Samsung Bioepis Responds To Rumor Of Biogen Biosimilars Buyout
Korean Media Suggests Former Partner Could Acquire Remaining Biosimilars Business
Rumors of another major biosimilars deal are spreading after Korean media reported that Samsung Bioepis could be considering a bid for Biogen’s biosimilars business.
